- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Gross profit margin of select U.S. biotech and drugs companies Q3 2018
Gross profit margin of select U.S. biotech and drugs companies Q3 2018
Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
This statistic shows the gross profit margin of selected U.S.-based biotech and drugs companies as of third quarter of 2018. In that quarter, U.S. biotech company AbbVie reported an profit margin of nearly 78 percent. In general, profit margins are very high among biotech companies.
Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
Loading statistic...
Expand statistic
| Gross profit margin | |
|---|---|
| General Cannabis Corp | 95.21% |
| Seattle Genetics | 92.71% |
| Biogen | 86.6% |
| Allergan | 84.74% |
| Amgen | 82.44% |
| Gilead Sciences | 80.59% |
| Entia Biosciences (Q4) | 77.99% |
| Abbvie | 77.72% |
| Nanostring Technologies | 67.53% |
| U.S. Stem Cell | 63.8% |
| Emergent Biosolutions | 57.83% |
| Asterias Biotherapeutics | 50.86% |
| United Cannabis Corp. | 26.51% |
| Gross profit margin | |
|---|---|
| General Cannabis Corp | 95.21% |
| Seattle Genetics | 92.71% |
| Biogen | 86.6% |
| Allergan | 84.74% |
| Amgen | 82.44% |
| Gilead Sciences | 80.59% |
| Entia Biosciences (Q4) | 77.99% |
| Abbvie | 77.72% |
| Nanostring Technologies | 67.53% |
| U.S. Stem Cell | 63.8% |
| Emergent Biosolutions | 57.83% |
| Asterias Biotherapeutics | 50.86% |
| United Cannabis Corp. | 26.51% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the gross profit margin of selected U.S.-based biotech and drugs companies as of third quarter of 2018. In that quarter, U.S. biotech company AbbVie reported an profit margin of nearly 78 percent. In general, profit margins are very high among biotech companies.
Show more- Show sources information
- Show publisher information
- Release date
- October 2018
- Region
- Worldwide, United States
- Survey time period
- as of 3rd quarter 2018
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- October 2018
More information
- Region
- Worldwide, United States
- Survey time period
- as of 3rd quarter 2018
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Allergan
- 45 page/s
- English
- pptx
- Detailed references
Everything On "Allergan" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2017 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2017 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018Change in global biotech-pharma industry stock indices 2018
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017Projected return on biopharma R&D investments U.S. 2010-2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2019
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)Acreage of genetically modified crops worldwide 2003-2017
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2017, by country
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2018
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Insulin-replacement medications - revenues 2010
- Key figures on U.S. public biotech companies 2012-2016
- United States biotech financing data 2012-2016
- Biotech company distribution by geographical location
- Number of biotech companies in the U.S. 2012-2016
- Global biotech industry revenue by geographical location 2013-2016
- Projected 2018 revenue for top 10 drugs approved U.S. 2013
- Pharma and biotech - average p/e ratios in 2005 and 2010
- Projected 2024 revenue for top drugs approved U.S. 2018
- Projected 2019 revenue for top drugs approved U.S. 2014
- Projected 2020 revenue for top drugs approved in U.S. 2015
- Commercial leaders vs. other companies in European biotech 2014
- European countries based on number of public biotech companies 2010
- Revenue of top growing private specialty pharmacies in U.S. 2017
- Latin America: antimicrobial coatings revenue 2018-2023
- Revenue of biotechnology in the U.S., 2009-2014
- Industry revenue of »research, experimental development on biotechnology« in Croatia 2011-...
- Industry revenue of »research, experimental development on biotechnology« in Sweden 2011-2...
- Revenue of U.S. public bioscience firms by size class 2009
Studies
- Biotechnology in Germany
- Biotechnology Industry in Europe
- Pharmaceutical trends in Europe
- Celgene Corporation - 2018 Form 10-K
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- Biogen Inc. - 2018 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- Indicatori Farmaceutici
- The 2018 Genentech Oncology Trend Report
- PAGB Annual Review 2017-2018
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical industry in China
Statistics on "Biotech industry"
- Global top 10 companies based on biotech prescription drug revenue in 2017 and 2024 (in billion U.S. dollars)*
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)
- Selected top biotechnology companies based on number of employees worldwide in 2017
- Value of the NASDAQ biotech Index from 2010 to 2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*
- Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
- Expected top life science startups in the United States in 2019*
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)
- Revenues from leading insulin-replacement medications in 2010 (in billion euros)
- Key figures on U.S. public biotech companies from 2012 to 2016
- Financing data of U.S. biotech companies from 2012 to 2016
- Biotechnology company distribution by geographical location in 2010
- Number of biotechnology companies in the United States from 2012 to 2016
- Global biotechnology industry revenue by selected geographical location from 2013 to 2016 (in billion U.S. dollars)*
- Projected 2018 revenue for top 10 drugs approved in the U.S. in 2013 (in million U.S. dollars)
- Average price-to-earnings ratios in U.S. big pharma and big biotech in 2005 and 2010
- Projected 2024 revenue for selected top drugs approved in the U.S. in 2018 (in million U.S. dollars)
- Projected 2019 revenue for top drugs approved in the U.S. in 2014 (in billion U.S. dollars)
- Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)
- Commercial leaders vs. other companies in European biotechnology in 2014
- Leading European countries based on the number of public biotech companies in 2010
- Fastest-growing private specialty pharmacies in the U.S. in 2017, by revenue (in million U.S. dollars)
- Antimicrobial coatings market value in Latin America in 2018 and 2023 (in million U.S. dollars)
- Revenue of biotechnology (NAICS NN001) in the United States from 2009 to 2014 (in billion U.S. dollars)
- Industry revenue of »research, experimental development on biotechnology« in Croatia from 2011 to 2023 (in million U.S. Dollars)
- Industry revenue of »research, experimental development on biotechnology« in Sweden from 2011 to 2023 (in million U.S. Dollars)
- Revenue of U.S. public bioscience firms by revenue size class in 2009 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.